Ondansetron 4mg/2ml IV
Original notice title
Belgium – Various medicinal products – Ondansetron
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
20 / 100
Risk factors
No procurement documents were provided; technical specifications and full terms are unknown
The notice and likely all documents are in Dutch; non-Dutch speakers may struggle
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- VITAZ vzw
- Country
- Belgium
- CPV
- 33690000 - Various medicinal products
- Deadline
- Jul 22, 2026
- Estimated value
- EUR 288k
Overview
Moderate opportunityKey Facts
- EUR 288k estimated value
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Aug 2030
- Supply of Ondansetron 4mg/2ml IV injection
- Framework agreement with single contractor for 4 years (2026-2030)
Show full summary
This tender is for a framework agreement for the supply of Ondansetron 4mg/2ml IV (medicinal product) to VITAZ vzw in Sint-Niklaas, Belgium. The procedure is open, with one lot. The contract is valued at a maximum framework amount of €288,000 EUR for a duration of 4 years (2026-2030). Award is based solely on price (100% weight). Submission deadline is 2026-07-22 at 09:30 local time. The tender notice is in Dutch and only an XML notice was analyzed; no procurement documents were provided.
Risks
No procurement documents were provided; technical specifications and full terms are unknown
The notice and likely all documents are in Dutch; non-Dutch speakers may struggle
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Open procedure
- One lot, no variants allowed
Administrative
- Electronic submission via Open portal
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Name
Location
Sint-Niklaas, BEL
Website
Buyer profile
Identifier
0881.291.322
Activity
Health
Lots (1)
LOT-0001
Ondansetron 4mg/2ml IV
Supply of Ondansetron 4mg/2ml IV injection via a framework agreement with one contractor. Delivery on call to the contracting authority in Sint-Niklaas, Belgium.
EUR 288k
Estimated value
Location
Duration
Category
Award Criteria
Deadline
Award details
Prijs
Value note
Framework maximum value
Show original TED data
Original TED description
Deze opdracht betreft het afsluiten van een raamovereenkomst met één opdrachtnemer waarbij alle voorwaarden voor de uitvoering van deze opdracht worden vastgelegd. Het doel van de raamovereenkomst is de levering van geneesmiddelen door de opdrachtnemer op afroep van de aanbesteders gedurende de looptijd beschreven in het bestek. Voor verdere toelichting verwijzen wij naar de technische bepalingen van het bestek.
Procurement Details
- Publication date
- 18 Jun 2026
- Languages
- Dutch
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 423861-2026
Documents (2)
Similar tenders
Spain – Various medicinal products – Suministro de medicamentos destinado a terapias genicas mediante SDA
Italy – Various medicinal products – Bando V SDA farmaci
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на КОЦ-Русе ЕООД
Italy – Various medicinal products – ARIA_2025_045
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на УМБАЛ "Царица Йоанна-ИСУЛ" ЕАД
Italy – Various medicinal products – Bando SDA Farmaci, Emoderivati, Vaccini e Mezzi di contrasto - Terza edizione
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
20 / 100
Risk factors
No procurement documents were provided; technical specifications and full terms are unknown
The notice and likely all documents are in Dutch; non-Dutch speakers may struggle
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications